BONE MARROW LEUKAEMIC CELL INFILTRATION

This adverse event was reported 82 times

These drugs are most commonly taken by patients reporting BONE MARROW LEUKAEMIC CELL INFILTRATION:

# Drug Count
0 BLINATUMOMAB 31
1 METHOTREXATE SODIUM 18
2 METHOTREXATE 16
3 CYCLOPHOSPHAMIDE 14
4 CYCLOPHOSPHAMIDE FOR INJECTION 14
5 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 14
6 DEXAMETHASONE 13
7 DEXAMETHASONE 1.5 MG 13
8 CYTARABINE 9
9 VENETOCLAX 9
See all common drugs associated with BONE MARROW LEUKAEMIC CELL INFILTRATION

BONE MARROW LEUKAEMIC CELL INFILTRATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BENZETHONIUM CHLORIDE 1 0.0078
1 BLINATUMOMAB 31 0.0029
2 PLATINUM 1 0.0019
3 INOTUZUMAB OZOGAMICIN 5 0.0017
4 NELARABINE 1 0.0010
5 CLOFARABINE 2 0.0009
6 PONATINIB HYDROCHLORIDE 4 0.0008
7 IBRITUMOMAB TIUXETAN 1 0.0007
8 MICAFUNGIN SODIUM 4 0.0006
9 CHLORAMBUCIL 2 0.0005
See all drugs enriched for association with BONE MARROW LEUKAEMIC CELL INFILTRATION